Long-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis
- 1 November 1995
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 48 (5), 1435-1450
- https://doi.org/10.1038/ki.1995.433
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats.JCI Insight, 1993
- Experience with the preclinical assessment of basic fibroblast growth factor (bFGF)Toxicology Letters, 1992
- Rat glomerular mesangial cells synthesize basic fibroblast growth factor. Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis.JCI Insight, 1992
- Basic fibroblast growth factor is efficiently released from a cytolsolic storage site through plasma membrane disruptions of endothelial cellsJournal of Cellular Physiology, 1991
- Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor.Proceedings of the National Academy of Sciences, 1991
- Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix.Cell Regulation, 1990
- Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries.JCI Insight, 1990
- Biological and biochemical properties of fibroblast growth factors. Implications for the pathogenesis of atherosclerosis.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like moleculesBiochemistry, 1989
- Structural Characterization and Biological Functions of Fibroblast Growth FactorEndocrine Reviews, 1987